Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07129395 · ClinicalTrials.gov registry record
Anticoagulation Adherence Measurement Strategies
A clinical trial of Anticoagulation, sponsored by Children's Hospital Medical Center, Cincinnati.
- Active
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT07129395: Active study of Anticoagulation, sponsored by Children's Hospital Medical Center, Cincinnati.
NCT07129395 is a study of Anticoagulation that is active but no longer recruiting, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07129395, a study of Anticoagulation, is active but no longer recruiting, sponsored by Children's Hospital Medical Center, Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Single center study to evaluate the feasibility of using 3 different strategies to measure adherence among children, adolescents, and young adults prescribed an anticoagulation medication
Primary Outcome
Participants will be provided with a MEMS® Cap if they are prescribed an oral medication and a MEMS® Injectable if they are prescribed an injectable medication. Patients and families will then be trained by study nurse coordinator (NC) or principal investigator (PI) regarding how to use the MEMS® for medication administration throughout the study.
Conditions Studied
Study Locations (1)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-09 |
| Est. Completion | 2026-10-04 |
What the registry record for NCT07129395 still lists
NCT07129395 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Anticoagulation appearing as the primary indexed condition, and to 0 interventions.
NCT07129395 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT07129395 about?
NCT07129395 is a clinical study titled "Anticoagulation Adherence Measurement Strategies". Single center study to evaluate the feasibility of using 3 different strategies to measure adherence among children, adolescents, and young adults prescribed an anticoagulation medication
What is the current status of trial NCT07129395?
This trial is currently active not recruiting. The enrollment target is 30 participants. The study started on 2023-01-09. Estimated completion is 2026-10-04.
What conditions does trial NCT07129395 study?
This clinical trial studies the following conditions: Anticoagulation.
Who is sponsoring clinical trial NCT07129395?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07129395 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anticoagulation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI